Physicochemical Properties, Formulation, and Drug Delivery

Drug Delivery: Principles and Applications

Volumn , Issue , 2005, Pages 57-71

  Barich, Dewey H ^a   Munson, Eric J ^a   Zell, Mark T ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b PFIZER INC   (United States)

Author keywords

Drug formulation and delivery; Oral drug delivery method; Stability and solubility

Indexed keywords

EID: 65449158566     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471475734.ch4     Document Type: Chapter

References (39)

1. Lee, T. W.-L.; Robinson, J. R. In Remington: The Science and Practice of Pharmacy; Limmer, D., Ed. Lippincott Williams & Wilkins: Baltimore, 2000, p. 2077.
2. Rao, V. M.; Haslam, J. L.; Stella, V. J. J. Pharm. Sci. 2001, 90, 807-816.
3. Uekama, K.; Hieda, Y.; Hirayama, F.; Arima, H.; Sudoh, M.; Yagi, A.; Terashima, H. Pharm. Res. 2001, 18, 1578-1585.
4. Okimoto, K.; Miyake, M.; Ohnishi, N.; Rajewski, R. A.; Stella, V. J.; Irie, T.; Uekama, K. Pharm. Res. 1998, 15, 1562-1568.
5. Stella, V. J.; Martodihardjo, S.; Katsuhide, T.; Venkatramana, M. R. J. Pharm. Sci. 1998, 87, 1235-1241.
6. Stella, V. J. Adv. Drug Deliv. Rev. 1996, 19, 311-330.
7. Boucher, B. A. Pharmacotherapy 1996, 16, 777-791.
8. Acosta, E. P.; Fletcher, C. V. Ann. Pharmacotherapy 1997, 31, 185-191.
9. Perry, C. M.; Faulds, D. Drugs 1996, 52, 754-772.
10. Shinkai, I.; Ohta, Y. Bioorg. Med. Chem. 1996, 4, 1-2.
11. Budman, D. R. Invest. New Drugs 2000, 18, 355-363.
12. Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Porter, W.; Morris, J. Pharm. Res. 2001, 18, 859-866.
13. Yamanouchi Inc., 2003.
14. Yoshioka, S.; Stella, V. J. Stability of Drugs and Dosage Forms. Kluwer Academic/ Plenum: New York, 2000.
15. Edwards, L. J. Trans. Faraday Soc. 1950, 46, 723-735.
16. Garrett, E. R. J. Am. Chem. Soc. 1957, 79, 3401-3408.
17. Koshy, K. T.; Lach, J. L. J. Pharm. Sci. 1961, 50, 113-118.
18. Brownley, C. A., Jr.; Lachman, L. J. Pharm. Sci. 1964, 53, 452-454.
19. Koshy, K. T.; Duvall, R. N.; Troup, A. E.; Pyles, J. W. J. Pharm. Sci. 1965, 54, 549-554.
20. Wolfrom, M. L.; Schuetz, R. D.; Calvalieri, L. F. J. Am. Chem. Soc. 1948, 70, 514-517.
21. Taylor, R. B.; Jappy, B. M.; Neil, J. M. J. Pharm. Pharmacology 1972, 24, 121-129.
22. Taylor, R. B.; Sood, V. C. J. Pharm. Pharmacol. 1978, 30, 510-511.
23. Nassar, M. N.; House, C. A.; Agharkar, S. N. J. Pharm. Sci. 1992, 81, 1088-1091.
24. Jivani, S. G.; Stella, V. J. J. Pharm. Sci. 1985, 74, 1274-1282.
25. Hamilton-Miller, J. M. T. J. Pharm. Pharmacology 1973, 25, 401-407.
26. Snider, B. G.; Runge, T. A.; Fagerness, P. E.; Robins, R. H.; Kaluzny, B. D. Int. J. Pharm. 1990, 66, 63-70.
27. Loftsson, T.; Baldvinsdottir, J. Acta Pharm. Nord. 1992, 4, 129-132.
28. van der Houwen, O. A. G. J.; Teeuwsen, J.; Bekers, O.; Beijnen, J. H.; Bult, A.; Underberg, W. J. M. Int. J. Pharm. 1994, 105, 249-254.
29. Musson, D. G.; Evitts, D. P.; Bidgood, A. M.; Olejnik, O. Int. J. Pharm. 1993, 99, 85-92.
30. Allen, L. V., Jr.; Erickson, M. A., III Am. J. Health-Sys. Pharm. 1998, 55, 1915-1920.
31. Nahata, M. C.; Morosco, R. S.; Hipple, T. F. Am. J. Health-Sys. Pharm. 1998, 55, 1155-1157.
32. Stanisz, B. J. Pharm. Biomed. Anal. 2003, 31, 375-380.
33. Jarho, P.; Jarvinen, K.; Urtti, A.; Stella, V. J.; Jarvinen, T. Int. J. Pharm. 1997, 153, 225-233.
34. I. P. E. C.-Americas, http://www.ipecamericas.org. 2003.
35. Byrn, S. R.; Pfeiffer, R. R.; Stowell, J. G. Solid-State Chemistry of Drugs, 2nd ed. SSCI: West Lafayette, IN, 1999.
36. Zell, M. T.; Padden, B. E.; Grant, D. J. W.; Schroeder, S. A.; Wachholder, K. L.; Prakash, I.; Munson, E. J. Tetrahedron 2000, 56, 6603-6616.
37. Gibson, M., Ed. Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commercial Dosage Form. Interpharm Press: Englewood, CO, 2002.
38. Moreton, R. C. In Excipients and Delivery Systems for Pharmaceutical Formulations; Royal Society of Chemistry: Cambridge, 1995, pp. 12-22.
39. Owens, D. R.; Zinman, B.; Bolli, G. Diabet. Med. 2003, 20, 886-898.